Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

W.Va. Amendment Marks Obstacle For Aid-In-Dying Movement No Photo Available

Gianna Ferrarin

A first-of-its-kind prohibition in West Virginia on medically assisted suicide represents a new form of opposition to a growing moveme... (more story)

Congress' Dash For Telehealth Extensions: 4 Things To Know No Photo Available

Mark Payne

With Republicans set to take control of Congress and the White House, lame-duck lawmakers on Capitol Hill are in a mad dash to pass le... (more story)

No 'Tin Hats': Fluoride Ruling Offers Options As RFK Eyes Ban No Photo Available

Dan McKay

A California federal court decision that plunged deep into the scientific research on fluoride's impact on human health may offer Robe... (more story)